• Ideaship invested in Hemex Health in a minority equity transaction to back expansion of rapid point-of-care blood diagnostics.
• Hemex Health’s Gazelle platform tests hemoglobin-related conditions with laboratory-level accuracy in about eight minutes.
• Hemex Health operates in more than 40 countries, targeting low-resource and remote settings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ideaship LLC published the original content used to generate this news brief on September 01, 2026, and is solely responsible for the information contained therein.